Cargando…

Las arritmias en la amiloidosis cardiaca

Cardiac amyloidosis (CA) is a form of cardiomyopathy characterized by the extracellular deposit of protein fibers in the myocardium, leading to the development of heart failure, arrhythmias, and electrical conduction system alterations. It is known that most cardiomyopathies have a close relationshi...

Descripción completa

Detalles Bibliográficos
Autores principales: Salinas-Arce, Jorge, Alca-Clares, Raúl, Gonzales-Luna, Ana Cecilia, Cabrera-Saldaña, Mario, Mendoza-Novoa, Pablo, Solórzano-Altamirano, Paula, Guevara-Valdivia, Milton
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Nacional Cardiovascular - INCOR 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284580/
https://www.ncbi.nlm.nih.gov/pubmed/37351307
http://dx.doi.org/10.47487/apcyccv.v3i2.217
_version_ 1785061433677971456
author Salinas-Arce, Jorge
Alca-Clares, Raúl
Gonzales-Luna, Ana Cecilia
Cabrera-Saldaña, Mario
Mendoza-Novoa, Pablo
Solórzano-Altamirano, Paula
Guevara-Valdivia, Milton
author_facet Salinas-Arce, Jorge
Alca-Clares, Raúl
Gonzales-Luna, Ana Cecilia
Cabrera-Saldaña, Mario
Mendoza-Novoa, Pablo
Solórzano-Altamirano, Paula
Guevara-Valdivia, Milton
author_sort Salinas-Arce, Jorge
collection PubMed
description Cardiac amyloidosis (CA) is a form of cardiomyopathy characterized by the extracellular deposit of protein fibers in the myocardium, leading to the development of heart failure, arrhythmias, and electrical conduction system alterations. It is known that most cardiomyopathies have a close relationship with heart rhythm abnormalities, however, CA is specially related to different kinds of arrhythmias even in pre-diagnosis stages. Arrhythmias like atrial fibrillation are present in up to 70% of patients with CA associated with a high risk of cardioembolic complications independent of the risk stratification. Ventricular arrhythmias are frequent, but the use of implantable cardioverter defibrillator has not been demonstrated to improve survival. The Atrial-Ventricular node disease is also common, and is frequently associated with the implantation of a pacemaker, even in asymptomatic patients. In this review, we clarify the recommendations of the most current guidelines, summarize historical and contemporaneous data and describe evidence-based strategies for the management of arrhythmias and their complications in CA.
format Online
Article
Text
id pubmed-10284580
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Instituto Nacional Cardiovascular - INCOR
record_format MEDLINE/PubMed
spelling pubmed-102845802023-06-22 Las arritmias en la amiloidosis cardiaca Salinas-Arce, Jorge Alca-Clares, Raúl Gonzales-Luna, Ana Cecilia Cabrera-Saldaña, Mario Mendoza-Novoa, Pablo Solórzano-Altamirano, Paula Guevara-Valdivia, Milton Arch Peru Cardiol Cir Cardiovasc Artículo De Revisión Cardiac amyloidosis (CA) is a form of cardiomyopathy characterized by the extracellular deposit of protein fibers in the myocardium, leading to the development of heart failure, arrhythmias, and electrical conduction system alterations. It is known that most cardiomyopathies have a close relationship with heart rhythm abnormalities, however, CA is specially related to different kinds of arrhythmias even in pre-diagnosis stages. Arrhythmias like atrial fibrillation are present in up to 70% of patients with CA associated with a high risk of cardioembolic complications independent of the risk stratification. Ventricular arrhythmias are frequent, but the use of implantable cardioverter defibrillator has not been demonstrated to improve survival. The Atrial-Ventricular node disease is also common, and is frequently associated with the implantation of a pacemaker, even in asymptomatic patients. In this review, we clarify the recommendations of the most current guidelines, summarize historical and contemporaneous data and describe evidence-based strategies for the management of arrhythmias and their complications in CA. Instituto Nacional Cardiovascular - INCOR 2022-06-27 /pmc/articles/PMC10284580/ /pubmed/37351307 http://dx.doi.org/10.47487/apcyccv.v3i2.217 Text en https://creativecommons.org/licenses/by-nc/4.0/Este es un artículo publicado en acceso abierto bajo una licencia Creative Commons
spellingShingle Artículo De Revisión
Salinas-Arce, Jorge
Alca-Clares, Raúl
Gonzales-Luna, Ana Cecilia
Cabrera-Saldaña, Mario
Mendoza-Novoa, Pablo
Solórzano-Altamirano, Paula
Guevara-Valdivia, Milton
Las arritmias en la amiloidosis cardiaca
title Las arritmias en la amiloidosis cardiaca
title_full Las arritmias en la amiloidosis cardiaca
title_fullStr Las arritmias en la amiloidosis cardiaca
title_full_unstemmed Las arritmias en la amiloidosis cardiaca
title_short Las arritmias en la amiloidosis cardiaca
title_sort las arritmias en la amiloidosis cardiaca
topic Artículo De Revisión
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284580/
https://www.ncbi.nlm.nih.gov/pubmed/37351307
http://dx.doi.org/10.47487/apcyccv.v3i2.217
work_keys_str_mv AT salinasarcejorge lasarritmiasenlaamiloidosiscardiaca
AT alcaclaresraul lasarritmiasenlaamiloidosiscardiaca
AT gonzaleslunaanacecilia lasarritmiasenlaamiloidosiscardiaca
AT cabrerasaldanamario lasarritmiasenlaamiloidosiscardiaca
AT mendozanovoapablo lasarritmiasenlaamiloidosiscardiaca
AT solorzanoaltamiranopaula lasarritmiasenlaamiloidosiscardiaca
AT guevaravaldiviamilton lasarritmiasenlaamiloidosiscardiaca